Izaflortaucipir F-18

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameIzaflortaucipir F-18
Drug Alias NameTau-PET tracer - AC Immune(18F)MNI-960(18F)-PI2620MNI-960 F-18PI-2620 F-18 +[8] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsCognitive DysfunctionOpioid-Related DisordersFrontotemporal Lobar Degeneration +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySpain
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPiramalAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesLife Molecular Imaging GmbHPiramalAc Immune Sa +[5] 
Inactive CompaniesLife Molecular Imaging Sa
Active IndicationsCognitive DysfunctionOpioid-Related DisordersFrontotemporal Lobar Degeneration +[6] 
Inactive IndicationsBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A